THE TOP NEWS IN MARIJUANA LAW REFORM — Volume 27, Issue 22
2024 CWCBExpo & NORML FORML
Sponsored ad
 
NORML News of the Week
 

THE TOP NEWS IN MARIJUANA LAW REFORM

Volume 27   •   Issue 22   •   May 30, 2024

Clinical Trial: CBD-Infused Gel Relieves Osteoarthritic Hand Pain

Clinical Trial: CBD-Infused Gel Relieves Osteoarthritic Hand Pain

CBD application is associated with improvements in pain, grip strength, fatigue, muscle stiffness, and anxiety.

 
Study: History of Cannabis Use Associated With Lower Risk of Prostate Cancer

Study: History of Cannabis Use Associated With Lower Risk of Prostate Cancer

Scientists suggest that this finding provides "biological support for the anti-cancer effects of the constituents of marijuana."

 
 

LATEST NEWS

 
 
Tell the DEA That Cannabis Doesn’t Belong in Schedule I

Tell the DEA That Cannabis Doesn’t Belong in Schedule I

The US Drug Enforcement Administration is currently accepting comments from the public on whether to reclassify cannabis via the Federal eRulemaking Portal.

 
 

ACTION ALERTS

 
 
Federal: House Committee Approves Amendment Barring Production of Hemp-Derived Intoxicating Products

Federal: House Committee Approves Amendment Barring Production of Hemp-Derived Intoxicating Products

The amendment targets products containing cannabinoids that "are not capable of being naturally produced" by the hemp plant or that are the result of a chemical synthesis.

 
 

NORML IN THE MEDIA

 
 
NORML FORML

NORML's mission is supported by thousands of people across America as we work to reform marijuana laws in all 50 states and at the federal level.

Can you chip in $5 today to help us keep up the fight?
 
NORML and The NORML Foundation
1420 K Street, NW, Suite 350
Washington, DC xxxxxx

(202) 483-5500[email protected]
Facebook Twitter Instagram YouTube LinkedIn
Cannabis policy should be evidence-based.
Dispel marijuana myths with the NORML Fact Sheets.

Too many emails? Update your subscription preferences or unsubscribe at the link below.